These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 10433574
1. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. Schmitt H, Schnitzler N, Riehl J, Adam G, Sieberth HG, Haase G. Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574 [Abstract] [Full Text] [Related]
2. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. Roche B, Rozenberg S, Cambau E, Desplaces N, Dion E, Dubourg G, Koeger AC, Robin H, Vergeron H, Bourgeois P. Rev Rhum Engl Ed; 1997 Jan; 64(1):64-5. PubMed ID: 9051864 [No Abstract] [Full Text] [Related]
3. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. Tomiyama Y, Maesaki S, Yong B, Higashiyama Y, Miyazaki Y, Tomono K, Tashiro T, Kohno S. Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036 [Abstract] [Full Text] [Related]
4. Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice. Lounis N, Truffot-Pernot C, Bentoucha A, Robert J, Ji B, Grosset J. Antimicrob Agents Chemother; 2001 Nov; 45(11):3229-30. PubMed ID: 11600387 [Abstract] [Full Text] [Related]
5. Successful management of two heart transplant recipients with mycobacterial pulmonary infections. Bossert T, Bittner HB, Richter M, Rahmel A, Barten M, Gummert JF, Mohr FW. Ann Thorac Surg; 2005 Aug; 80(2):719-21. PubMed ID: 16039241 [Abstract] [Full Text] [Related]
6. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. Gochi M, Kaneko Y, Seki A, Saitou Z, Samejima T, Seki Y, Takeda H, Kinoshita A, Kuwano K. Kekkaku; 2012 Nov; 87(11):733-6. PubMed ID: 23367833 [Abstract] [Full Text] [Related]
7. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi]. Gevaudan MJ, Bollet C, Mallet MN, de Lamballerie X, Sambuc R, de Micco P. Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093 [Abstract] [Full Text] [Related]
8. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R. J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [Abstract] [Full Text] [Related]
9. [A case of pulmonary infection with mycobacterium xenopi]. Kawamura M, Kusanagi Y, Satou Y, Itou S, Honma M, Shimoide H. Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):86-9. PubMed ID: 9611983 [Abstract] [Full Text] [Related]
10. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. Lipsky BA, Unowsky J, Zhang H, Townsend L, Talbot GH. Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620 [Abstract] [Full Text] [Related]
11. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. N Engl J Med; 1996 Aug 08; 335(6):377-83. PubMed ID: 8676931 [Abstract] [Full Text] [Related]
12. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Gordin FM, Sullam PM, Shafran SD, Cohn DL, Wynne B, Paxton L, Perry K, Horsburgh CR. Clin Infect Dis; 1999 May 08; 28(5):1080-5. PubMed ID: 10452638 [Abstract] [Full Text] [Related]
13. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Al Jarad N, Demertzis P, Jones DJ, Barnes NC, Rudd RM, Gaya H, Wedzicha JA, Hughes DT, Empey DW. Thorax; 1996 Feb 08; 51(2):137-9. PubMed ID: 8711643 [Abstract] [Full Text] [Related]
14. Polyarthralgia-arthritis syndrome induced by low doses of rifabutin. Le Gars L, Collon T, Picard O, Kaplan G, Berenbaum F. J Rheumatol; 1999 May 08; 26(5):1201-2. PubMed ID: 10332992 [Abstract] [Full Text] [Related]
15. New antimycobacterial agents. Yew WW, Chau CH. Monaldi Arch Chest Dis; 1996 Oct 08; 51(5):394-404. PubMed ID: 9009628 [Abstract] [Full Text] [Related]
16. [Two cases of pulmonary Mycobacterium xenopi infection]. Yamazaki Y, Fujiuchi S, Matsumoto H, Takahashi T, Takeda A, Fujita Y, Fujikane T, Shimizu T, Nishigaki Y. Nihon Kokyuki Gakkai Zasshi; 2003 Aug 08; 41(8):556-60. PubMed ID: 14503343 [Abstract] [Full Text] [Related]
17. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Thorax; 2008 Jul 08; 63(7):627-34. PubMed ID: 18250184 [Abstract] [Full Text] [Related]
18. The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Fisher M, Tomlinson DR, Coker RJ. Int J STD AIDS; 1996 Jul 08; 7(4):244-9; quiz 249-51. PubMed ID: 8876354 [No Abstract] [Full Text] [Related]